| Report Title | Price | Action |
|---|---|---|
| Oxysterols Receptor LXR Alpha (Liver X Receptor Alpha or Nuclear Receptor Subfamily 1 Group H Member 3 or LXRA or NR1H3) - Drugs in Development, 2021
Oxysterols Receptor LXR Alpha (Liver X Receptor Alpha or Nuclear Receptor Subfamily 1 Group H Member 3 or LXRA or NR1H3) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) - Drugs in Development, 2021
Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) - Drugs in Development, 2021 Summary Major Prion Protein (ASCR or PrP27-30 or P...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Pervasive Developmental Disorder (PDD) (Central Nervous System) - Drugs in Development, 2021
Pervasive Developmental Disorder (PDD) (Central Nervous System) - Drugs in Development, 2021 Summary Pervasive Developmental Disorder (PDD) (Central...
Published: Apr-2021 | No. of Pages: 95
|
$ 2000 | |
| Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021
Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021 Summary Antiphospholipid Syndrome (Hematological Disorders) - Drugs...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Platelet Derived Growth Factor Receptor (PDGFR or EC 2.7.10.1) - Drugs in Development, 2021
Platelet Derived Growth Factor Receptor (PDGFR or EC 2.7.10.1) - Drugs in Development, 2021 Summary Platelet Derived Growth Factor Receptor (PDGFR o...
Published: Apr-2021 | No. of Pages: 70
|
$ 3000 | |
| Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or CLN1 or PPT1 or EC 3.1.2.22) - Drugs in Development, 2021
Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or CLN1 or PPT1 or EC 3.1.2.22) - Drugs in Development, 2021 Summary Palmitoyl Prote...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Mitogen Activated Protein Kinase Kinase Kinase 14 (NF Kappa Beta Inducing Kinase or Serine/Threonine Protein Kinase NIK or MAP3K14 or EC 2.7.11.25) - Drugs in Development, 2021
Mitogen Activated Protein Kinase Kinase Kinase 14 (NF Kappa Beta Inducing Kinase or Serine/Threonine Protein Kinase NIK or MAP3K14 or EC 2.7.11.25) - ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Enterobacteriaceae Infections (Infectious Disease) - Drugs in Development, 2021
Enterobacteriaceae Infections (Infectious Disease) - Drugs in Development, 2021 Summary Enterobacteriaceae Infections (Infectious Disease) - Drugs i...
Published: Apr-2021 | No. of Pages: 95
|
$ 2000 | |
| Cytopenia (Hematological Disorders) - Drugs in Development, 2021
Cytopenia (Hematological Disorders) - Drugs in Development, 2021 Summary Cytopenia (Hematological Disorders) - Drugs in Development, 2021 provides a...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Sodium/Glucose Cotransporter 2 (Low Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 2 or SGLT2 or SLC5A2) - Drugs in Development, 2021
Sodium/Glucose Cotransporter 2 (Low Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 2 or SGLT2 or SLC5A2) - Drugs in Developme...
Published: Apr-2021 | No. of Pages: 70
|
$ 3000 | |
| Peptidyl Prolyl Cis-Trans Isomerase F Mitochondrial (Cyclophilin D or Cyclophilin F or Mitochondrial Cyclophilin or Rotamase F or PPIF or EC 5.2.1.8) - Drugs in Development, 2021
Peptidyl Prolyl Cis-Trans Isomerase F Mitochondrial (Cyclophilin D or Cyclophilin F or Mitochondrial Cyclophilin or Rotamase F or PPIF or EC 5.2.1.8) ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Myeloperoxidase (MPO or EC 1.11.2.2) - Drugs in Development, 2021
Myeloperoxidase (MPO or EC 1.11.2.2) - Drugs in Development, 2021 Summary Myeloperoxidase (MPO or EC 1.11.2.2) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Chronic Myelomonocytic Leukemia (CMML) (Oncology) - Drugs in Development, 2021
Chronic Myelomonocytic Leukemia (CMML) (Oncology) - Drugs in Development, 2021 Summary Chronic Myelomonocytic Leukemia (CMML) (Oncology) - Drugs in ...
Published: Apr-2021 | No. of Pages: 95
|
$ 2000 | |
| Churg-Strauss Syndrome (Immunology) - Drugs in Development, 2021
Churg-Strauss Syndrome (Immunology) - Drugs in Development, 2021 Summary Churg-Strauss Syndrome (Immunology) - Drugs in Development, 2021 provides a...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Calcineurin (Protein Serine/Threonine Phosphatase 3 or Protein Phosphatase 3 or EC 3.1.3.16) - Drugs in Development, 2021
Calcineurin (Protein Serine/Threonine Phosphatase 3 or Protein Phosphatase 3 or EC 3.1.3.16) - Drugs in Development, 2021 Summary Calcineurin (Prote...
Published: Apr-2021 | No. of Pages: 80
|
$ 3000 | |
| ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021
ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021 Summary ALK Tyrosine Kinase Re...
Published: Apr-2021 | No. of Pages: 70
|
$ 3000 | |
| Phosphodiesterase 9 (PDE9 or EC 3.1.4.35) - Drugs in Development, 2021
Phosphodiesterase 9 (PDE9 or EC 3.1.4.35) - Drugs in Development, 2021 Summary Phosphodiesterase 9 (PDE9 or EC 3.1.4.35) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Neuromedin K Receptor (NK3 Receptor or Neurokinin B Receptor or Tachykinin Receptor 3 or NK3R or TACR3) - Drugs in Development, 2021
Neuromedin K Receptor (NK3 Receptor or Neurokinin B Receptor or Tachykinin Receptor 3 or NK3R or TACR3) - Drugs in Development, 2021 Summary Neurome...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Pediatric Diffuse Intrinsic Pontine Glioma (Oncology) - Drugs in Development, 2021
Pediatric Diffuse Intrinsic Pontine Glioma (Oncology) - Drugs in Development, 2021 Summary Pediatric Diffuse Intrinsic Pontine Glioma (Oncology) - D...
Published: Apr-2021 | No. of Pages: 95
|
$ 2000 | |
| Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021
Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 Summary Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 |